Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
25.10
+1.27 (5.33%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Harrow Employees
Harrow had 382 employees as of December 31, 2024. The number of employees increased by 67 or 21.27% compared to the previous year.
Employees
382
Change (1Y)
67
Growth (1Y)
21.27%
Revenue / Employee
$522,550
Profits / Employee
-$45,762
Market Cap
893.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
HROW News
- 20 hours ago - NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. - PRNewsWire
- 14 days ago - Harrow Expands VEVYE® Access for All Program to ImprimisRx's Klarity-C Patients - Business Wire
- 26 days ago - Harrow: When Cheaper Doesn't Mean Attractive (Rating Upgrade) - Seeking Alpha
- 27 days ago - Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call - Seeking Alpha
- 27 days ago - Harrow Inc.: Roll The Dice For Strong Upside Prospects As Earnings Ramp - Seeking Alpha
- 4 weeks ago - Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results - Business Wire
- 4 weeks ago - Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Business Wire
- 4 weeks ago - Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL - Business Wire